Mark Massaro
Stock Analyst at BTIG
(0.38)
# 4,082
Out of 4,386 analysts
1010
Total ratings
35.1%
Success rate
-2.4%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Reiterated: Buy | $80 | $48.59 | +64.64% | 10 | Jun 1, 2026 | |
| GH Guardant Health | Reiterated: Buy | $145 → $160 | $124.89 | +28.11% | 47 | May 27, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $5.72 | - | 23 | May 15, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $2.5 | $0.9581 | +160.93% | 24 | May 15, 2026 | |
| TKNO Alpha Teknova | Reiterated: Hold | n/a | $4.65 | - | 12 | May 14, 2026 | |
| MXCT MaxCyte | Reiterated: Hold | n/a | $1.15 | - | 29 | May 13, 2026 | |
| MDXH MDxHealth | Reiterated: Buy | $7 → $4 | $0.546 | +632.60% | 14 | May 13, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $50 → $40 | $20.12 | +98.81% | 34 | May 13, 2026 | |
| XGN Exagen | Reiterated: Buy | $9 → $8 | $4.20 | +90.48% | 25 | May 12, 2026 | |
| PSNL Personalis | Maintained: Buy | $13 → $11 | $10.04 | +9.56% | 37 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $32 | $16.14 | +98.27% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $130 | $94.43 | +37.67% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $16.70 | +31.74% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.28 | +51.52% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 → $90 | $51.80 | +73.75% | 35 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $4 | $2.60 | +53.85% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.95 | - | 34 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $28 | $21.95 | +27.56% | 32 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $9 → $5 | $8.09 | -38.20% | 27 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $260 | $213.47 | +21.80% | 77 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $78.82 | +102.99% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $561.17 | +42.56% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.17 | - | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $1.21 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.002 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $75 | $14.47 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $4.15 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $3.13 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 → $310 | $158.04 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $173 → $170 | $262.01 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $112 → $113 | $197.21 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.40481 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $25.69 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $149 → $145 | $149.99 | n/a | 2 | May 7, 2015 |
Tempus AI
Jun 1, 2026
Reiterated: Buy
Price Target: $80
Current: $48.59
Upside: +64.64%
Guardant Health
May 27, 2026
Reiterated: Buy
Price Target: $145 → $160
Current: $124.89
Upside: +28.11%
Insight Molecular Diagnostics
May 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.72
Upside: -
Lucid Diagnostics
May 15, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.9581
Upside: +160.93%
Alpha Teknova
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.65
Upside: -
MaxCyte
May 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.15
Upside: -
MDxHealth
May 13, 2026
Reiterated: Buy
Price Target: $7 → $4
Current: $0.546
Upside: +632.60%
Castle Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $50 → $40
Current: $20.12
Upside: +98.81%
Exagen
May 12, 2026
Reiterated: Buy
Price Target: $9 → $8
Current: $4.20
Upside: +90.48%
Personalis
May 11, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $10.04
Upside: +9.56%
May 7, 2026
Reiterated: Buy
Price Target: $38 → $32
Current: $16.14
Upside: +98.27%
May 7, 2026
Maintained: Buy
Price Target: $140 → $130
Current: $94.43
Upside: +37.67%
May 6, 2026
Reiterated: Buy
Price Target: $22
Current: $16.70
Upside: +31.74%
May 6, 2026
Reiterated: Buy
Price Target: $8
Current: $5.28
Upside: +51.52%
May 5, 2026
Reiterated: Buy
Price Target: $170 → $90
Current: $51.80
Upside: +73.75%
May 1, 2026
Upgraded: Buy
Price Target: $4
Current: $2.60
Upside: +53.85%
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $10.95
Upside: -
Apr 29, 2026
Reiterated: Buy
Price Target: $26 → $28
Current: $21.95
Upside: +27.56%
Mar 12, 2026
Rated: Sell
Price Target: $9 → $5
Current: $8.09
Upside: -38.20%
Mar 3, 2026
Reiterated: Buy
Price Target: $230 → $260
Current: $213.47
Upside: +21.80%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $78.82
Upside: +102.99%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $561.17
Upside: +42.56%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.17
Upside: -
May 20, 2024
Maintained: Buy
Price Target: $2
Current: $1.21
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.002
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 17, 2019
Maintained: Buy
Price Target: $70 → $75
Current: $14.47
Upside: n/a
Nov 10, 2019
Maintained: Hold
Price Target: $7 → $8
Current: $4.15
Upside: n/a
Nov 6, 2019
Maintained: Buy
Price Target: $35
Current: $3.13
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $300 → $310
Current: $158.04
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $173 → $170
Current: $262.01
Upside: n/a
Oct 22, 2019
Maintained: Buy
Price Target: $112 → $113
Current: $197.21
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.40481
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $25.69
Upside: n/a
May 7, 2015
Maintained: Hold
Price Target: $149 → $145
Current: $149.99
Upside: n/a